FDA
approval
· 2024-09-16
FDA Approved: LISDEXAMFETAMINE DIMESYLATE — Supplemental Application (Amneal Pharmaceuticals LLC)
Summary
FDA approved Amneal Pharmaceuticals LLC's supplemental application to market lisdexamfetamine dimesylate as a generic drug, expanding access to a lisdexamfetami…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for LISDEXAMFETAMINE DIMESYLATE (LISDEXAMFETAMINE)